Ray Villar's Colleagues at QED Therapeutics
Ray Villar's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Ray Villar's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Ray Villar
Ray Villar currently works for QED Therapeutics.
Ray Villar's role at QED Therapeutics is CMC Technical Writer.
Ray Villar's email address is ***@qedtx.com. To view Ray Villar's full email address, please signup to ConnectPlex.
Ray Villar works in the Biotechnology industry.
Ray Villar's colleagues at QED Therapeutics are Kimberly Richards, Shugufa Afifi, Chelsea Wolfe, Dr.Meenakshi Srivastava, Jacob Mercer, Liz Bergan, Brett Kuenne and others.
Ray Villar's phone number is 650-231-4088